US health officials warn consumers of two more eye drop recalls due to contamination risks that could lead to vision problems and serious injury
The announcements follow a recall last month of Indian-made eye drops linked to an outbreak of drug-resistant infections. One person died and at least five others had permanent vision loss.
There is no indication that the latest recalls are related to those products.
The Food and Drug Administration issued separate recall notices for certain eye drops distributed by Pharmamedica and Apotex after the companies said they are voluntarily withdrawing several lots of their products from the market.
Pharmedica said Friday it is recalling two batches of Purely Soothing 15% MSM Drops due to issues “that could lead to blindness.” The over-the-counter drops are designed to treat eye irritation. The Phoenix-based company said consumers would immediately stop using the drops and return them to where they were purchased.
The recall affects nearly 2,900 bottles, according to the company. The drops are manufactured in Arizona.
Last week, the FDA posted a separate recall notice from Apotex recalling six lots of prescription eye drops used to treat a form of glaucoma. The company said it launched the recall after finding cracks in some caps.
The drops are distributed as Brimonidine Tartrate Ophthalmic Solution. 0.15% and were sold between last April and February.
Both companies said the recalls were conducted in consultation with the FDA.
The Associated Press Health and Science division is supported by the Science and Educational Media Group of the Howard Hughes Medical Institute. The AP is solely responsible for all content.